The findings reviewed by GME stated that the Global Immunoprotein Diagnostic Testing Market will expand with a CAGR value of 6.5%. In recent years, the number of cases of chronic diseases like cancer, cardiovascular diseases, obesity, and autoimmune diseases has been on the rise. The rising awareness of early detection and its benefits has increased the demand for immunoprotein diagnostic testing.
Browse 159 Market Data Tables and 119 Figures
spread through 189 Pages and in-depth TOC on "Immunoprotein Diagnostic Testing Market - Forecast to 2026"
https://www.globalmarketestimates.com/market-report/global-immunoprotein-diagnostic-testing-market-2806
By Type (C-reactive Protein Diagnostic Test,
Complement System Protein Diagnostic Test, Pre-albumin Diagnostic Test,
Haptoglobin Diagnostic Test, Immunoglobulin Diagnostic Test, Free Light Chain
Diagnostic Test, Others), By Application (Autoimmune Testing, Infectious
Disease Testing, Allergy Testing, Endocrine Testing, Oncology Testing,
Toxicology Testing, Others), By Technology (Radioimmunoassay, Immunoturbidity
Assay, Immunoprotein Electrophoresis, Enzyme-Linked Immunosorbent Assay
(Chemiluminescence Immunoassay, Fluorescence Immunoassay, Colorimetric
Immunoassay), Others),By Region
(North America, Asia Pacific, CSA, Europe, and the Middle East and Africa);
End-User Landscape, Company Market Share Analysis & Competitor Analysis
Key Market Insights
·
Immunoprotein diagnostic testingisa diagnostic
technique carried out to study the immune system of the body through the
immunoproteins present.
·
The increasing
geriatric population and rising investment and adoption of immunoprotein
diagnostic testing are the major drivers of the market.
·
As per the technology outlook, it is analyzed that
the immunoglobulin diagnostic testing segment will have a lion’s share in the
market from 2021 to 2026
Browse the
Report @ https://www.globalmarketestimates.com/market-report/global-immunoprotein-diagnostic-testing-market-2806
Type Outlook (Revenue, USD Billion, 2021-2026)
·
C-reactive Protein
Diagnostic Test
·
Complement System
Protein Diagnostic Test
·
Pre-albumin Diagnostic
Test
·
Haptoglobin Diagnostic
Test
·
Immunoglobulin
Diagnostic Test
·
Free Light Chain
Diagnostic Test
·
Others
Application Outlook (Revenue, USD Billion,
2021-2026)
·
Autoimmune Testing
·
Infectious Disease
Testing
·
Allergy Testing
·
Endocrine Testing
·
Oncology Testing
·
Toxicology Testing
·
Others
Technology Outlook (Revenue, USD Billion,
2021-2026)
·
Radioimmunoassay
·
Immunoturbidity Assay
·
Immunoprotein
Electrophoresis
·
Enzyme-Linked
Immunosorbent Assay
·
Chemiluminescence
Immunoassay
·
Fluorescence
Immunoassay
·
Colorimetric
immunoassay
·
Others
Regional Outlook
(Revenue, USD Billion, 2021-2026)
North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of APAC
Central
& South America
- Brazil
- Argentina
- Rest of CSA
Middle
East & Africa
- Saudi Arabia
- UAE
- Rest of MEA
Contact:
Tracy Simon
Email address: tracy.simon@globalmarketestimates.com
Phone
Number: +16026667238
Website:
https://www.globalmarketestimates.com/
No comments:
Post a Comment